HUMAN GROWTH HORMONE

HUMAN GROWTH HORMONE was reported 70 times

HUMAN GROWTH HORMONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MULTIPLE EPIPHYSEAL DYSPLASIA 3 0.1111
1 BLOOD BILIRUBIN UNCONJUGATED 1 0.0714
2 BLOOD CANNABINOIDS INCREASED 1 0.0417
3 DRUG METABOLISING ENZYME DECREASED 1 0.0192
4 NATURAL KILLER CELL COUNT INCREASED 1 0.0167
5 FAILED IN VITRO FERTILISATION 1 0.0164
6 TOE WALKING 1 0.0085
7 ELBOW DEFORMITY 2 0.0058
8 IN VITRO FERTILISATION 1 0.0055
9 HEPATOSPLENIC T-CELL LYMPHOMA 2 0.0054
10 NEUROFIBROMATOSIS 1 0.0048
11 VICTIM OF CHILD ABUSE 1 0.0040
12 CSF PRESSURE INCREASED 1 0.0038
13 BODY HEIGHT BELOW NORMAL 2 0.0031
14 PANCREATIC ENLARGEMENT 1 0.0027
15 GENE MUTATION IDENTIFICATION TEST POSITIVE 1 0.0024
16 LOWER RESPIRATORY TRACT INFECTION VIRAL 1 0.0020
17 LIPOHYPERTROPHY 1 0.0016
18 IMPETIGO 2 0.0013
19 LIMB ASYMMETRY 1 0.0013
20 GENITAL INFECTION FUNGAL 1 0.0012
21 ADRENOCORTICOTROPIC HORMONE DEFICIENCY 1 0.0011
22 BINGE EATING 1 0.0009
23 CHRONIC FATIGUE SYNDROME 1 0.0007
24 GENITAL RASH 1 0.0007
25 HYPOTHALAMO-PITUITARY DISORDER 1 0.0007
26 PATHOLOGICAL GAMBLING 1 0.0006
27 HYPERSEXUALITY 1 0.0005
28 HYPERPHAGIA 2 0.0005
29 LIPIDS INCREASED 1 0.0005
30 FUNGAL SKIN INFECTION 2 0.0005
31 COMPULSIVE SHOPPING 1 0.0005
32 INSULIN RESISTANCE 1 0.0005
33 TIC 2 0.0004
34 CLONUS 1 0.0004
35 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
36 GROWTH RETARDATION 1 0.0003
37 HISTIOCYTOSIS HAEMATOPHAGIC 1 0.0003
38 PRIAPISM 1 0.0003
39 JAUNDICE CHOLESTATIC 1 0.0003
40 PULMONARY FUNCTION TEST DECREASED 1 0.0002
41 SYNOVIAL CYST 1 0.0002
42 SKIN TIGHTNESS 1 0.0002
43 HYPOVOLAEMIC SHOCK 1 0.0002
44 FOETAL DEATH 1 0.0002
45 LEARNING DISABILITY 1 0.0002
46 INTRACRANIAL PRESSURE INCREASED 1 0.0002
47 PRE-EXISTING CONDITION IMPROVED 1 0.0002
48 APPLICATION SITE VESICLES 1 0.0002
49 DEFAECATION URGENCY 1 0.0001
50 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
51 JOINT STIFFNESS 3 0.0001
52 RESPIRATORY RATE INCREASED 1 0.0001
53 BONE DISORDER 2 0.0001
54 NERVE COMPRESSION 1 0.0001
55 ATELECTASIS 1 0.0001
56 AUTOIMMUNE DISORDER 1 0.0001
57 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
58 FOLLICULITIS 1 0.0001
59 RETCHING 2 0.0001
60 SKIN LACERATION 1 0.0001
61 STATUS EPILEPTICUS 1 0.0001
62 DERMATITIS CONTACT 1 0.0001
63 ACCIDENT 1 0.0001
64 ADRENAL INSUFFICIENCY 1 0.0001
65 MUSCLE SPASTICITY 1 0.0001
66 ABASIA 2 0.0001
67 DRUG TOXICITY 1 0.0001
68 CORONARY ARTERY OCCLUSION 1 0.0001
69 INCORRECT DRUG ADMINISTRATION DURATION 2 0.0001
70 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
71 SEASONAL ALLERGY 1 0.0001
72 PARALYSIS 1 0.0001
73 HYPOKINESIA 1 0.0001
74 GASTROENTERITIS 1 0.0001
75 INJECTION SITE RASH 2 0.0001
76 ANKLE FRACTURE 1 0.0001
77 OBESITY 1 0.0001
78 DRUG LEVEL INCREASED 1 0.0001
79 BLOOD UREA INCREASED 1 0.0001
80 MULTI-ORGAN FAILURE 1 0.0001
81 HEPATIC STEATOSIS 1 0.0001
82 SLEEP APNOEA SYNDROME 1 0.0001
83 PRESCRIBED OVERDOSE 1 0.0001
84 SKIN FISSURES 1 0.0001
85 INTENTIONAL DRUG MISUSE 1 0.0000
86 IRRITABLE BOWEL SYNDROME 1 0.0000
87 FAECES DISCOLOURED 1 0.0000
88 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
89 APPLICATION SITE PAIN 1 0.0000
90 ORAL PAIN 1 0.0000
91 APPLICATION SITE PRURITUS 1 0.0000
92 LOCALISED INFECTION 1 0.0000
93 RASH GENERALISED 1 0.0000
94 EXPOSURE VIA SKIN CONTACT 1 0.0000
95 BLOOD BILIRUBIN INCREASED 1 0.0000
96 INTERNATIONAL NORMALISED RATIO INCREASED 1 0.0000
97 NEEDLE ISSUE 1 0.0000
98 ACUTE MYOCARDIAL INFARCTION 1 0.0000
99 LABORATORY TEST ABNORMAL 1 0.0000
100 EPILEPSY 1 0.0000
101 NERVOUS SYSTEM DISORDER 1 0.0000
102 MOOD SWINGS 1 0.0000
103 HYPOTHYROIDISM 1 0.0000
104 LACTIC ACIDOSIS 1 0.0000
105 CHOLELITHIASIS 1 0.0000
106 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
107 CRYING 1 0.0000
108 C-REACTIVE PROTEIN INCREASED 1 0.0000
109 PANIC ATTACK 1 0.0000
110 INJECTION SITE SWELLING 2 0.0000
111 ARTHRITIS 2 0.0000
112 ABORTION SPONTANEOUS 1 0.0000
113 DEVICE BREAKAGE 1 0.0000
114 DRUG ABUSE 2 0.0000
115 HYPERHIDROSIS 3 0.0000
116 DEVICE LEAKAGE 1 0.0000
117 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
118 SKIN DISCOLOURATION 1 0.0000
119 HYPOKALAEMIA 1 0.0000
120 OCULAR HYPERAEMIA 1 0.0000
121 RASH ERYTHEMATOUS 1 0.0000
122 MULTIPLE SCLEROSIS 1 0.0000
123 FLUSHING 2 0.0000
124 THERAPY CESSATION 1 0.0000
125 HAEMOGLOBIN DECREASED 2 0.0000
126 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1 0.0000
127 NERVOUSNESS 1 0.0000
128 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
129 DISTURBANCE IN ATTENTION 1 0.0000
130 OEDEMA 1 0.0000
131 DEPENDENCE 1 0.0000
132 HAEMATOCHEZIA 1 0.0000
133 WEIGHT INCREASED 4 0.0000
134 HYPONATRAEMIA 1 0.0000
135 CATARACT 1 0.0000
136 IRRITABILITY 1 0.0000
137 THERAPEUTIC RESPONSE DECREASED 1 0.0000
138 STOMATITIS 1 0.0000
139 ILL-DEFINED DISORDER 1 0.0000
140 FEELING HOT 1 0.0000
141 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
142 EXPOSURE DURING PREGNANCY 1 0.0000
143 BLOOD GLUCOSE INCREASED 3 0.0000
144 GAIT DISTURBANCE 3 0.0000
145 PRODUCT DOSE OMISSION 1 0.0000
146 BLOOD CREATININE INCREASED 1 0.0000
147 INFUSION RELATED REACTION 1 0.0000
148 BLOOD PRESSURE DECREASED 1 0.0000
149 MEMORY IMPAIRMENT 2 0.0000
150 RESPIRATORY FAILURE 1 0.0000
151 UNDERDOSE 1 0.0000
152 UNEVALUABLE EVENT 1 0.0000
153 INFLUENZA LIKE ILLNESS 1 0.0000
154 DRUG DOSE OMISSION 2 0.0000
155 URTICARIA 2 0.0000
156 ABDOMINAL DISCOMFORT 2 0.0000
157 BALANCE DISORDER 1 0.0000
158 COVID-19 2 0.0000
159 INSOMNIA 3 0.0000
160 TACHYCARDIA 1 0.0000
161 MUSCLE SPASMS 2 0.0000
162 SWELLING 1 0.0000
163 DRUG INTOLERANCE 1 0.0000
164 PRODUCT DOSE OMISSION ISSUE 3 0.0000
165 DYSPEPSIA 1 0.0000
166 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 2 0.0000
167 SINUSITIS 1 0.0000
168 ERYTHEMA 2 0.0000
169 ARTHRALGIA 4 0.0000
170 ABDOMINAL DISTENSION 1 0.0000
171 INFLUENZA 1 0.0000
172 ASTHMA 1 0.0000
173 DEPRESSION 2 0.0000
174 INCORRECT DOSE ADMINISTERED 2 0.0000
175 SEIZURE 1 0.0000
176 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
177 CHILLS 1 0.0000
178 FEELING ABNORMAL 2 0.0000
179 JOINT SWELLING 1 0.0000
180 PSORIASIS 1 0.0000
181 VISION BLURRED 1 0.0000
182 ANXIETY 2 0.0000
183 PAIN IN EXTREMITY 2 0.0000
184 INJECTION SITE PAIN 2 0.0000
185 PERIPHERAL SWELLING 1 0.0000
186 NAUSEA 5 0.0000
187 CONFUSIONAL STATE 1 0.0000
188 TREMOR 1 0.0000
189 DIZZINESS 3 0.0000
190 TOXICITY TO VARIOUS AGENTS 1 0.0000
191 NO ADVERSE EVENT 1 0.0000
192 NASOPHARYNGITIS 1 0.0000
193 PRODUCT USE ISSUE 1 0.0000
194 DYSPNOEA 3 0.0000
195 PRURITUS 2 0.0000
196 ABDOMINAL PAIN UPPER 1 0.0000
197 HYPERTENSION 1 0.0000
198 BACK PAIN 1 0.0000
199 ABDOMINAL PAIN 1 0.0000
200 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000
201 DRUG INEFFECTIVE 4 0.0000
202 ASTHENIA 1 0.0000
203 FATIGUE 2 0.0000
204 VOMITING 1 0.0000
205 PAIN 1 0.0000
206 HEADACHE 1 0.0000
207 DIARRHOEA 1 0.0000
208 OFF LABEL USE 1 0.0000